Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Kelly

Showing results (51-60 of 220) with videos related to

Pageof 22
Sort By:
Chemmedchem|May 8, 2009
Design and synthesis of Trypanosoma brucei active 1-alkyloxy and 1-benzyloxyadamantano 2-guanylhydrazonesIoannis Papanastasiou, Andrew Tsotinis, Grigoris Zoidis, et al.
Journal of Medicinal Chemistry|May 6, 2011
Novel lipophilic acetohydroxamic acid derivatives based on conformationally constrained spiro carbocyclic 2,6-diketopiperazine scaffolds with potent trypanocidal activityChristos Fytas, Grigoris Zoidis, Nikolaos Tzoutzas, et al.
Bioorganic & Medicinal Chemistry Letters|February 14, 2012
Inhibitors of human histone deacetylase with potent activity against the African trypanosome Trypanosoma bruceiJohn M Kelly, Martin C Taylor, David Horn, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2005
Vitamin C biosynthesis in trypanosomes: a role for the glycosomeShane R Wilkinson, S Radhika Prathalingam, Martin C Taylor, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2018
Assessing the Effectiveness of Curative Benznidazole Treatment in Preventing Chronic Cardiac Pathology in Experimental Models of Chagas DiseaseAmanda Fortes Francisco, Shiromani Jayawardhana, Martin C Taylor, et al.
Critical Care Medicine|March 25, 2017
Using Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in Critical Care: A Systematic Review of the Evidence for Benefit or HarmJohn M Kelly, Gordon D Rubenfeld, Neil Masson, et al.
The Biochemical Journal|July 14, 2007
The terminal step in vitamin C biosynthesis in Trypanosoma cruzi is mediated by a FMN-dependent galactonolactone oxidaseFlora J Logan, Martin C Taylor, Shane R Wilkinson, et al.
BMC Genomics|January 20, 2012
Centromere-associated repeat arrays on Trypanosoma brucei chromosomes are much more extensive than predictedMaria C Echeverry, Christopher Bot, Samson O Obado, et al.
Cellular Microbiology|February 27, 2016
Host and parasite genetics shape a link between Trypanosoma cruzi infection dynamics and chronic cardiomyopathyMichael D Lewis, Amanda Fortes Francisco, Martin C Taylor, et al.
Parasitology|August 24, 2017
Biological factors that impinge on Chagas disease drug developmentAmanda F Francisco, Shiromani Jayawardhana, Michael D Lewis, et al.
Pageof 22

Showing results (51-60 of 220) with videos related to

Sort By:
Pageof 22
Chemmedchem|May 8, 2009
Design and synthesis of Trypanosoma brucei active 1-alkyloxy and 1-benzyloxyadamantano 2-guanylhydrazonesIoannis Papanastasiou, Andrew Tsotinis, Grigoris Zoidis, et al.
Journal of Medicinal Chemistry|May 6, 2011
Novel lipophilic acetohydroxamic acid derivatives based on conformationally constrained spiro carbocyclic 2,6-diketopiperazine scaffolds with potent trypanocidal activityChristos Fytas, Grigoris Zoidis, Nikolaos Tzoutzas, et al.
Bioorganic & Medicinal Chemistry Letters|February 14, 2012
Inhibitors of human histone deacetylase with potent activity against the African trypanosome Trypanosoma bruceiJohn M Kelly, Martin C Taylor, David Horn, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 10, 2005
Vitamin C biosynthesis in trypanosomes: a role for the glycosomeShane R Wilkinson, S Radhika Prathalingam, Martin C Taylor, et al.
Antimicrobial Agents and Chemotherapy|August 8, 2018
Assessing the Effectiveness of Curative Benznidazole Treatment in Preventing Chronic Cardiac Pathology in Experimental Models of Chagas DiseaseAmanda Fortes Francisco, Shiromani Jayawardhana, Martin C Taylor, et al.
Critical Care Medicine|March 25, 2017
Using Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in Critical Care: A Systematic Review of the Evidence for Benefit or HarmJohn M Kelly, Gordon D Rubenfeld, Neil Masson, et al.
The Biochemical Journal|July 14, 2007
The terminal step in vitamin C biosynthesis in Trypanosoma cruzi is mediated by a FMN-dependent galactonolactone oxidaseFlora J Logan, Martin C Taylor, Shane R Wilkinson, et al.
BMC Genomics|January 20, 2012
Centromere-associated repeat arrays on Trypanosoma brucei chromosomes are much more extensive than predictedMaria C Echeverry, Christopher Bot, Samson O Obado, et al.
Cellular Microbiology|February 27, 2016
Host and parasite genetics shape a link between Trypanosoma cruzi infection dynamics and chronic cardiomyopathyMichael D Lewis, Amanda Fortes Francisco, Martin C Taylor, et al.
Parasitology|August 24, 2017
Biological factors that impinge on Chagas disease drug developmentAmanda F Francisco, Shiromani Jayawardhana, Michael D Lewis, et al.
Pageof 22